3Jialal I,Devaraj S.Inflammation and athero-sclerosis:the value of the high-sensitivity C -reactive protein assay as a risk marker.Am J Clin Pathol,2001,116(Suppl):S108-115.
2[2]Alonso-Martinez JL,Llorente-Diez B.C-reactive protein as a predictor of improvement and readmisson in heart failure[J].Eur J Heart Fail,2002,4(3):331-6.
3[3]Berton G.Cordiano R C-reactive protein in acute myocardial infarction:association with heart failure[J].Am Heart J,2003 Jun,145(6):1094-101.
4[4]Levine B,Kalman J.Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.N Eng J Med,1990,323:236-241.
5[5]Misao J,Hayakawa Y.Expression of bcl-2 protein ,an inhibitor of apoptosis,and bax,an accelerator of apoptosis,in ventricular myocytes of human heart with myocardial infarction[J].Ciirculation,1996,94(7):1506-1512.
6[6]Vasan RS,Sullivan LM.Inflammatory markers an ubjects without prior myocardial infarction[J].The Framingham Heart Study Circulation,2003 Mar 25,107(11):1486-91.
7Makin A, Lip GY, Silverman S, et al. Peripheral vascular disease and hypertension: a forgotten association? J Hum Hypertens,2001,15 :447-454.
8Parikh A, Daneman D. Is carotid ultrasound a useful tool in assessing cardiovascular disease in individuals with diabetes? Diabetes Technol Ther, 2004,6: 65-69.
9Jialal I, Devaraj S. Inflammation and atherosclerosis:the value of the high-sensitivity C-reactive protein assay as a risk marker. Am J Clin Pathol, 2001,116 (Suppl):S108-115.
10European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.J Hypertens, 2003,21:1011-1053.
